Showing results 1 to 1 of 1
| Title | Author(s) | Issue Date | |
|---|---|---|---|
KEYNOTE-122: Phase 2 study of pembrolizumab versus standard-of-care chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal carcinoma Proceeding/Conference:Annals of Oncology | 2016 |